Pharming confirms Rhucin European MAA filing timeline - FOXBusiness
2009-03-31 01:03:13

Pharming confirms Rhucin European MAA filing timeline FOXBusiness To date, 150 HAE (Hereditary angioedema) patients have received a total of 334 therapeutic doses of Rhucin to treat acute angioedema attacks. 179 repeat doses have been administered to treat acute HAE attacks in 83 patients. The Company considers that ...